TrialBlood advances2023

Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.

Raymond Siu Ming Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.